Literature DB >> 28565876

Effects of 17β-estradiol and 2-methoxyestradiol on the oxidative stress-hypoxia inducible factor-1 pathway in hypoxic pulmonary hypertensive rats.

Li Wang1, Quan Zheng1, Yadong Yuan1, Yanpeng Li1, Xiaowei Gong1.   

Abstract

The present study aimed to investigate the effects of 17β-estradiol (E2) and 2-methoxyestradiol (2ME) on the oxidative stress-hypoxia inducible factor-1 (OS-HIF-1) pathway in hypoxic pulmonary hypertensive rats. Female Sprague-Dawley rats were divided randomly into 4 groups, as follows: i) Control (Group A); ii) ovariectomy (OVX) + hypoxia (Group B); iii) OVX + hypoxia + E2 injection (Group C); and iv) 2ME injection (Group D). The rats were maintained under hypoxic conditions for 8 weeks, and mean pulmonary artery pressure (mPAP) and pulmonary arteriole morphology were measured. The reactive oxygen species, superoxide dismutase (SOD), manganese superoxide dismutase (MnSOD), and copper-zinc superoxide dismutase (Cu/ZnSOD) levels in serum were also measured. MnSOD and HIF-1α expression levels in lung tissue were determined by western blotting and reverse transcription-quantitative polymerase chain reaction. The mPAP and arterial remodeling index were significantly elevated following chronic hypoxia exposure; however, experimental data revealed a reduced response in E2 and 2ME intervention rats. Compared with Group A, Group B had significantly elevated oxidative stress levels, as illustrated by increased serum ROS levels, decreased serum SOD and MnSOD levels and decreased MnSOD mRNA and protein expression levels in lung tissue. Furthermore, HIF-1α mRNA and protein expression in Group B was significantly elevated compared with Group A. E2 and 2ME intervention significantly attenuated the aforementioned parameter changes, suggesting that E2 and 2ME partially ameliorate hypoxic pulmonary hypertension. The underlying mechanism of this may be associated with the increase in MnSOD activity and expression and reduction in ROS level, which reduces the levels of transcription and translation of HIF-1α.

Entities:  

Keywords:  17β-estradiol; 2-methoxyestradiol; hypoxia; hypoxia inducible factor-1α; oxidative stress; pulmonary hypertension; rat

Year:  2017        PMID: 28565876      PMCID: PMC5443199          DOI: 10.3892/etm.2017.4243

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  38 in total

Review 1.  Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning.

Authors:  Gregg L Semenza
Journal:  Biochim Biophys Acta       Date:  2010-08-21

2.  Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in rats.

Authors:  Lamiaa A Ahmed; Al Arqam Z Obaid; Hala F Zaki; Azza M Agha
Journal:  Eur J Pharmacol       Date:  2014-07-22       Impact factor: 4.432

Review 3.  Lung cell hypoxia: role of mitochondrial reactive oxygen species signaling in triggering responses.

Authors:  Paul T Schumacker
Journal:  Proc Am Thorac Soc       Date:  2011-11

4.  A conserved family of prolyl-4-hydroxylases that modify HIF.

Authors:  R K Bruick; S L McKnight
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

5.  Digoxin inhibits development of hypoxic pulmonary hypertension in mice.

Authors:  Edsel M Abud; Julie Maylor; Clark Undem; Arjun Punjabi; Ari L Zaiman; Allen C Myers; J T Sylvester; Gregg L Semenza; Larissa A Shimoda
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

6.  Dose-dependent therapeutic effects of 2-Methoxyestradiol on Monocrotaline-Induced pulmonary hypertension and vascular remodelling.

Authors:  S P Tofovic; T Jones; G Petrusevska
Journal:  Prilozi       Date:  2010

Review 7.  A global view of pulmonary hypertension.

Authors:  Marius M Hoeper; Marc Humbert; Rogerio Souza; Majdy Idrees; Steven M Kawut; Karen Sliwa-Hahnle; Zhi-Cheng Jing; J Simon R Gibbs
Journal:  Lancet Respir Med       Date:  2016-03-12       Impact factor: 30.700

8.  Purification and characterization of hypoxia-inducible factor 1.

Authors:  G L Wang; G L Semenza
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

9.  2-Methoxyestradiol inhibits superoxide anion generation while it enhances superoxide dismutase activity in swine granulosa cells.

Authors:  Giuseppina Basini; Sujen Eleonora Santini; Francesca Grasselli
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

10.  Chronic arsenic exposure and angiogenesis in human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1α/COX-2 pathway.

Authors:  Jun He; Min Wang; Yue Jiang; Qiudan Chen; Shaohua Xu; Qing Xu; Bing-Hua Jiang; Ling-Zhi Liu
Journal:  Environ Health Perspect       Date:  2014-01-10       Impact factor: 9.031

View more
  10 in total

1.  2-Methoxyestradiol attenuates liver fibrosis in mice: implications for M2 macrophages.

Authors:  Thikryat Neamatallah; Ashraf B Abdel-Naim; Basma G Eid; Atif Hasan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-07       Impact factor: 3.000

2.  Rosiglitazone augments antioxidant response in the human trophoblast and prevents apoptosis†.

Authors:  Hamid-Reza Kohan-Ghadr; Brian A Kilburn; Leena Kadam; Eugenia Johnson; Bradley L Kolb; Javier Rodriguez-Kovacs; Michael Hertz; D Randall Armant; Sascha Drewlo
Journal:  Biol Reprod       Date:  2019-02-01       Impact factor: 4.285

3.  2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1α/TGF-β/Smad2 Axis.

Authors:  Ashraf B Abdel-Naim; Thikryat Neamatallah; Basma G Eid; Ahmed Esmat; Abdulmohsin J Alamoudi; Gamal S Abd El-Aziz; Osama M Ashour
Journal:  Oxid Med Cell Longev       Date:  2018-08-01       Impact factor: 6.543

4.  Influence of 2-Methoxyestradiol and Sex on Hypoxia-Induced Pulmonary Hypertension and Hypoxia-Inducible Factor-1-α.

Authors:  Craig K Docherty; Margaret Nilsen; Margaret R MacLean
Journal:  J Am Heart Assoc       Date:  2019-03-05       Impact factor: 5.501

Review 5.  Oxidative Stress and Its Implications in the Right Ventricular Remodeling Secondary to Pulmonary Hypertension.

Authors:  Matthew Mikhael; Christian Makar; Amir Wissa; Trixie Le; Mansoureh Eghbali; Soban Umar
Journal:  Front Physiol       Date:  2019-09-24       Impact factor: 4.566

Review 6.  Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension.

Authors:  Stevan P Tofovic; Edwin K Jackson
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

7.  NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.

Authors:  Yun Liu; Xiaowei Nie; Jinquan Zhu; Tianyan Wang; Yanli Li; Qian Wang; Zengxian Sun
Journal:  J Cell Mol Med       Date:  2020-12-19       Impact factor: 5.295

8.  Tanreqing Injection Regulates Cell Function of Hypoxia-Induced Human Pulmonary Artery Smooth Muscle Cells (HPASMCs) through TRPC1/CX3CL1 Signaling Pathway.

Authors:  Yonghong Xiang; Fei Zheng; Qinzhe Zhang; RunJuan Zhang; Haiyan Pan; Zongdong Pang; Shimin Dai; Yurong Zhang; Ye Wu; Lunkai Yao; Mengju Su; Luying Lan
Journal:  Oxid Med Cell Longev       Date:  2022-02-11       Impact factor: 6.543

9.  2-Methoxyestradiol TPGS Micelles Attenuate Cyclosporine A-Induced Nephrotoxicity in Rats through Inhibition of TGF-β1 and p-ERK1/2 Axis.

Authors:  Mohammed W Al-Rabia; Mohamed A Alfaleh; Hani Z Asfour; Waleed S Alharbi; Mohamed A El-Moselhy; Nabil A Alhakamy; Usama A Fahmy; Osama A A Ahmed; Omar Fahmy; Omar M Rashad; Abdulmohsin J Alamoudi; Ashraf B Abdel-Naim
Journal:  Antioxidants (Basel)       Date:  2022-07-30

Review 10.  Mitochondrial Regulation of the Hypoxia-Inducible Factor in the Development of Pulmonary Hypertension.

Authors:  Esraa M Zeidan; Mohammad Akbar Hossain; Mahmoud El-Daly; Mohammed A S Abourehab; Mohamed M A Khalifa; Ashraf Taye
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.